Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Japan Eyewear Holdings Co., Ltd. (5889.T)
JPY2,418.00
+4.00 (+0.17%)
JP JPX Healthcare Medical - Specialties
Address
712-2 Yoshiecho 916-0001
Sabae, JP
Sabae, JP
CEO
Toshihiro Muraki
Website
japan-eyewear-holdings.co.jp
IPO
2023-11-16
ISIN JP3389460001
Description
Japan Eyewear Holdings Co., Ltd., through its subsidiaries, engages in the designing, manufacturing, and selling eyeglasses in Japan. The company was incorporated in 2019 and is based in Sabae, Japan.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY2,418.00
+4.00 (+0.17%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
133.3K
Beta
0.37
Float Shares
6.84M
Free Float %
28.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +8.02% | +15.07% | +7.57% | +24.68% | +14.45% | +14.51% | +9.69% | +110.98% | +110.98% | +110.98% | +110.98% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
2,418.00
DCF (Unlevered)
7,858.42
+225.0%
DCF (Levered)
7,581.45
+213.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.87
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Specialties: +8.3%+11.8% ★ Q2'26: +15.8% (vs Q2'25)
-
EPS growth Medical - Specialties: +10.1%-5.3% Q2'26: +36.3% (vs Q2'25)
-
FCF margin FCF growth · Medical - Specialties: +51.3%+25.4% Q2'26: +12.3% (vs Q2'25)
-
EBIT margin Medical - Specialties: +12.6%+32.0% ★ Q2'26: +32.9% (vs Q2'25)
-
ROIC Medical - Specialties: +6.6%+13.1% ★ Q2'26: +13.5% (vs Q2'25)
-
Share dilution Medical - Specialties: 0.0%+0.0% Q2'26: +0.0% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×1.98× Q2'26: 1.94× (vs Q2'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jan 2024 actual |
Jan 2025 actual |
Jan 2026 2 Rev. Ana. 2 EPS Ana. |
Jan 2027 1 Rev. Ana. 1 EPS Ana. |
Jan 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
13.53B
est: 13.10B (+3.3%)
|
16.67B
est: 16.15B (+3.2%)
|
18.60B
18.50B – 18.70B
+15.2% YoY
|
21.45B
21.45B – 21.45B
+15.3% YoY
|
23.26B
23.26B – 23.26B
+8.4% YoY
|
| EBITDA |
5.19B
est: 6.46B (-19.7%)
|
7.01B
est: 8.70B (-19.4%)
|
10.02B
9.97B – 10.07B
+15.2% YoY
|
11.55B
11.55B – 11.55B
+15.3% YoY
|
12.53B
12.53B – 12.53B
+8.4% YoY
|
| EBIT |
3.70B
est: 5.14B (-27.9%)
|
5.33B
est: 7.91B (-32.6%)
|
9.11B
9.07B – 9.16B
+15.2% YoY
|
10.51B
10.51B – 10.51B
+15.3% YoY
|
11.39B
11.39B – 11.39B
+8.4% YoY
|
| Net Income |
2.22B
est: 2.43B (-8.8%)
|
3.99B
est: 3.22B (+23.9%)
|
3.84B
3.81B – 3.86B
+19.1% YoY
|
4.58B
4.58B – 4.58B
+19.4% YoY
|
5.29B
5.29B – 5.29B
+15.5% YoY
|
| SGA |
6.69B
est: 8.26B (-19.0%)
|
7.83B
est: 8.47B (-7.6%)
|
9.75B
9.70B – 9.80B
+15.2% YoY
|
11.24B
11.24B – 11.24B
+15.3% YoY
|
12.19B
12.19B – 12.19B
+8.4% YoY
|
| EPS |
92.59
est: 99.30 (-6.8%)
|
166.43
est: 131.55 (+26.5%)
|
156.70
155.69 – 157.71
+19.1% YoY
|
187.10
187.10 – 187.10
+19.4% YoY
|
216.10
216.10 – 216.10
+15.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-06-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-06-10 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-06-09 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-06-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-06-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-06-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-06-03 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-06-02 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-06-01 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
5.60B
OE per share TTM
228.36
Owner's Yield
10.67%
Maintenance CapEx ratio
40.38%
Maint CapEx / Avg PPE
48.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 9 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Militia Long/Short Equity ETF ORR | 0.33% | 452.0K | 14.19% |
| 2 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.06% | 223.8K | 0.58% |
| 3 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 30.4K | 0.30% |
| 4 | Dimensional - International Small Cap ETF DFIS | 0.00% | 112.9K | 0.39% |
| 5 | iShares Core TOPIX ETF 1475.T | 0.00% | 348.1K | 0.05% |
| 6 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 145.0K | 0.28% |
| 7 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 119.0K | 0.22% |
| 8 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | — | 0.24% |
| 9 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
7.74M
Shares Outstanding
24.20M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kaneko Shinya | CEO, President & Representative Director | — | male |
| Shibata Shunichi | CFO, GM of Mgt. Headquarter & Administration Department and Director | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 5889.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
